Loading...
Docoh

Concert Pharmaceuticals (CNCE)

Employees
Data from SEC filings
Employee count
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


At the 2021 Annual Meeting of Stockholders of Concert Pharmaceuticals, Inc. (the “Company”) held on June 10, 2021, the Company’s stockholders voted as follows:
1. The stockholders elected the nominees listed below as Class I Directors to the Company’s Board of Directors, to serve until the Company’s 2024 Annual Meeting of Stockholders.
Nominees:For:Withheld:Broker Non-Votes:
Peter Barton Hutt12,788,2174,409,6307,557,058
Wilfred E. Jaeger, M.D.13,611,6993,586,1487,557,058
Roger D. Tung, Ph.D.13,759,4163,438,4317,557,058

2. The stockholders approved, on a non-binding, advisory basis, the Company’s executive compensation.
For:15,201,561
Against:1,968,570
Abstain:27,716
Broker Non-Votes:7,557,058

3. The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021.
For:24,530,602
Against:223,295
Abstain:1,008
.